Improving Access to Safe Medicines Act of 2022

United States117th CongressHR-8931House of Representatives
Updated: Nov 1, 2022

Summary

Improving Access to Safe Medicines Act of 2022 This bill requires the Drug Enforcement Administration to issue a proposed rule to remove a drug from scheduling under the Controlled Substances Act within 180 days of a recommendation from the Food and Drug Administration to do so.

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

  1. Introduced in House

  2. Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    House of Representatives

  3. Referred to the Subcommittee on Health.

    House of Representatives

  4. Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

    House of Representatives

All available records shown.